Sera Prognostics, Inc

SERANASDAQ · Services-Medical Laboratories

Financing

SEC filings to 2026-10-05 · every row opens its filing

No share count on file in the XBRL facts for this window.

Newest

S-3 of 2024-08-07. Not read yet. S-3 ↗

$40.0M

William Blair, agreement of 2026-03-18. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

13.90M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

6.7 quarters

$46.4M on 2026-06-30 ÷ $6.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-02-10	Public offering incl. 11.25M pre-funded	12,500,000	$4.00	$50.0M	424B5 ↗